Company: SRPT
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058003
Chunk: 90

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 90
---
 of the shares vesting on each anniversary of the date of grant, subject to each such holder continuing to provide services to the Company through each such vesting date. (11) The 14,000 PSUs were earned in the third quarter of 2023 based upon the achievement of Non GAAP profitability goal, as described in " 2023 Equity Incentive Compensation " section of our 2023 proxy statement; an additional 25% of the PSU award (3,500 shares) were also earned in the fourth quarter of 2024 based on the achievement of one billion dollars in sales within 18 months following approval of SRP-9001. The earned PSUs of 17,500 shares fully vested on March 6, 2025.

<div align='center'>63</div>

(12) The RSUs fully vest on March 1, 2028, with 25% of the shares vesting on each anniversary of the date of grant, subject to each such holder continuing to provide services to the Company through each such vesting date. (13) The RSUs fully vest on November 16, 2025, with 25% of the shares vesting on each anniversary of the date of grant, subject to Dr. Rodino-Klapac continuing to provide services to the Company through each such vesting date. (14) The RSUs fully vested on March 3, 2025, with 25% of the shares vesting on each anniversary of the date of grant, subject to Mr. Arif continuing to provide services to the Company through each such vesting date. (15) The number of PSUs shown above represents the additional award that can be earned if maximum performance is achieved. The additional award was not achieved and therefore did not vest as of the service vesting date March 7, 2025. (16) The PSUs are earned based upon achievement of certain net revenue goal, positive cash flow goal and LGMD approval goal, as described in “ 2024 Equity Incentive Compensation ” in the " Compensation Discussion and Analysis " section of this 2024 proxy statement. The number of PSUs shown above represents the target award, but up to 125% of this target number of shares can be earned if maximum performance is achieved. To the extent earned, the PSUs will vest on March 1, 2026, subject to each such holder continuing to provide service to the Company through such vesting date. The following table